These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
467 related articles for article (PubMed ID: 10574244)
1. Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model. Rovers JP; Saarnak AE; Molina A; Schuitmaker JJ; Sterenborg HJ; Terpstra OT Br J Cancer; 1999 Oct; 81(4):600-8. PubMed ID: 10574244 [TBL] [Abstract][Full Text] [Related]
2. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo. Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168 [TBL] [Abstract][Full Text] [Related]
3. Outcome of mTHPC mediated photodynamic therapy is primarily determined by the vascular response. Triesscheijn M; Ruevekamp M; Aalders M; Baas P; Stewart FA Photochem Photobiol; 2005; 81(5):1161-7. PubMed ID: 15934792 [TBL] [Abstract][Full Text] [Related]
4. Optimisation of illumination for photodynamic therapy with mTHPC on normal colon and a transplantable tumour in rats. Tsutsui H; MacRobert AJ; Curnow A; Rogowska A; Buonaccorsi G; Kato H; Bown SG Lasers Med Sci; 2002; 17(2):101-9. PubMed ID: 12111593 [TBL] [Abstract][Full Text] [Related]
5. The pharmacokinetic behavior of the photosensitizer meso-tetra-hydroxyphenyl-chlorin in mice and men. Triesscheijn M; Ruevekamp M; Out R; Van Berkel TJ; Schellens J; Baas P; Stewart FA Cancer Chemother Pharmacol; 2007 Jun; 60(1):113-22. PubMed ID: 17009028 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of tetra(m-hydroxyphenyl)chlorin in human plasma and individualized light dosimetry in photodynamic therapy. Glanzmann T; Hadjur C; Zellweger M; Grosiean P; Forrer M; Ballini JP; Monnier P; van den Bergh H; Lim CK; Wagnières G Photochem Photobiol; 1998 May; 67(5):596-602. PubMed ID: 9613244 [TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy with mTHPC and polyethylene glycol-derived mTHPC: a comparative study on human tumour xenografts. Ris HB; Krueger T; Giger A; Lim CK; Stewart JC; Althaus U; Altermatt HJ Br J Cancer; 1999 Mar; 79(7-8):1061-6. PubMed ID: 10098737 [TBL] [Abstract][Full Text] [Related]
8. Optimizing light dosimetry in photodynamic therapy of early stage carcinomas of the esophagus using fluorescence spectroscopy. Braichotte DR; Savary JF; Monnier P; van den Bergh HE Lasers Surg Med; 1996; 19(3):340-6. PubMed ID: 8923430 [TBL] [Abstract][Full Text] [Related]
9. Experimental evaluation of possible side effects of intra-operative photodynamic therapy on rabbit blood vessels and nerves. Kübler AC; Stenzel W; Rühling M; Meul B; Fischer JH Lasers Surg Med; 2003; 33(4):247-55. PubMed ID: 14571449 [TBL] [Abstract][Full Text] [Related]
10. Optimizing meso-tetra-hydroxyphenyl-chlorin-mediated photodynamic therapy for basal cell carcinoma. Triesscheijn M; Ruevekamp M; Antonini N; Neering H; Stewart FA; Baas P Photochem Photobiol; 2006; 82(6):1686-90. PubMed ID: 16984216 [TBL] [Abstract][Full Text] [Related]
11. Meta-tetra(hydroxyphenyl)chlorin photodynamic therapy in early-stage squamous cell carcinoma of the head and neck. Copper MP; Tan IB; Oppelaar H; Ruevekamp MC; Stewart FA Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):709-11. PubMed ID: 12874068 [TBL] [Abstract][Full Text] [Related]
12. Effect of the TAT-RasGAP(317-326) peptide on apoptosis of human malignant mesothelioma cells and fibroblasts exposed to meso-tetra-hydroxyphenyl-chlorin and light. Pittet O; Petermann D; Michod D; Krueger T; Cheng C; Ris HB; Widmann C J Photochem Photobiol B; 2007 Jul; 88(1):29-35. PubMed ID: 17560792 [TBL] [Abstract][Full Text] [Related]
13. Correlation between in vivo pharmacokinetics, intratumoral distribution and photodynamic efficiency of liposomal mTHPC. Lassalle HP; Dumas D; Gräfe S; D'Hallewin MA; Guillemin F; Bezdetnaya L J Control Release; 2009 Mar; 134(2):118-24. PubMed ID: 19100297 [TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy as novel nephron sparing treatment option for small renal masses. Kroeze SG; Grimbergen MC; Rehmann H; Bosch JL; Jans JJ J Urol; 2012 Jan; 187(1):289-95. PubMed ID: 22099991 [TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy using meta-tetrahydroxyphenylchlorin (Foscan) for the treatment of vulval intraepithelial neoplasia. Campbell SM; Gould DJ; Salter L; Clifford T; Curnow A Br J Dermatol; 2004 Nov; 151(5):1076-80. PubMed ID: 15541088 [TBL] [Abstract][Full Text] [Related]
16. Biodistribution and bioactivity of tetra-pegylated meta-tetra(hydroxyphenyl)chlorin compared to native meta-tetra(hydroxyphenyl)chlorin in a rat liver tumor model. Rovers JP; Saarnak AE; de Jode M; Sterenborg HJ; Terpstra OT; Grahn MF Photochem Photobiol; 2000 Feb; 71(2):211-7. PubMed ID: 10687396 [TBL] [Abstract][Full Text] [Related]
17. Tissue levels, histologic changes and plasma pharmacokinetics of meta-Tetra (hydroxyphenyl) chlorin (mTHPC) in the cat. Campbell GA; Bartels KE; Arnold C; Healey T; Cowell RL; Lucroy MD; Ronn AM Lasers Med Sci; 2002; 17(2):79-85. PubMed ID: 12111590 [TBL] [Abstract][Full Text] [Related]
19. Calculation of singlet oxygen dose from photosensitizer fluorescence and photobleaching during mTHPC photodynamic therapy of MLL cells. Dysart JS; Singh G; Patterson MS Photochem Photobiol; 2005; 81(1):196-205. PubMed ID: 15469385 [TBL] [Abstract][Full Text] [Related]
20. Influence of incubation time and sensitizer localization on meta-tetra(hydroxyphenyl)chlorin (mTHPC)-induced photoinactivation of cells. Sasnouski S; Pic E; Dumas D; Zorin V; D'Hallewin MA; Guillemin F; Bezdetnaya L Radiat Res; 2007 Aug; 168(2):209-17. PubMed ID: 17638401 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]